{"id":"W3172195548","doi":"10.1200/jco.2021.39.15_suppl.5519","title":"Molecular results and potential biomarkers identified from MILO/ENGOT-ov11 phase 3 study of binimetinib versus physicians choice of chemotherapy (PCC) in recurrent low-grade serous ovarian cancer (LGSOC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; KRAS; Internal medicine; Oncology; Logistic regression; Progression-free survival; Proportional hazards model; Vemurafenib; Cancer; Chemotherapy; Metastatic melanoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001397751,0.0002740894,0.0005410884,0.0003671623,0.0001755259,0.0005103761,0.0002054219,0.0003368065,0.002964601],"category_scores_gemma":[0.001418288,0.0001782286,0.0004392503,0.0003652932,0.0002621446,0.0003362742,0.000181555,0.0007149247,0.0002424366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006782622,"about_ca_system_score_gemma":0.0005925125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006605007,"about_ca_topic_score_gemma":0.00235224,"domain_scores_codex":[0.9995728,0.0001653607,0.00003399947,0.00009172401,0.00007331982,0.00006286784],"domain_scores_gemma":[0.9991725,0.0002446529,0.0002773193,0.00004532482,0.00005884562,0.0002013433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3862928,0.007336332,0.3979183,0.0007568425,0.002190264,0.0003437656,0.0002719498,0.003780649,0.06073846,0.0006737354,0.009994748,0.1297021],"study_design_scores_gemma":[0.03911998,0.126408,0.7931576,0.0001102273,0.002783009,0.001261665,0.0002037268,0.005105775,0.02050234,0.0007059597,0.01058127,0.00006039073],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936461,0.001457541,0.0002443177,0.0002064041,0.00002119451,0.0002471755,0.002819498,0.00001883063,0.001339027],"genre_scores_gemma":[0.994548,0.0003580346,0.0005023608,0.0001962603,0.00001774578,0.0001806508,0.003470686,0.000007604449,0.0007186317],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002964601,"threshold_uncertainty_score":0.009917617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1035399851569736,"score_gpt":0.4774920960452308,"score_spread":0.3739521108882572,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}